COLLEGIUM PHARMACEUTICAL, INC Logo

COLLEGIUM PHARMACEUTICAL, INC

Develops and commercializes abuse-deterrent medications for responsible chronic pain management.

COLL | NDAQ

Overview

Corporate Details

ISIN(s):
US19459J1043
LEI:
Country:
United States of America
Address:
100 TECHNOLOGY CENTER DRIVE, 2072 STOUGHTON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Collegium Pharmaceutical, Inc. is a specialty biopharmaceutical company dedicated to developing and commercializing medications for people with serious medical conditions. The company's primary focus is on pain management, offering a portfolio of differentiated products designed to treat chronic pain responsibly. A key aspect of its scientific approach is the development of abuse-deterrent formulations. Collegium is engaged in the full lifecycle of its products, from development to commercialization and distribution in the United States, supporting both patients and healthcare providers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all COLLEGIUM PHARMACEUTICAL, INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for COLLEGIUM PHARMACEUTICAL, INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for COLLEGIUM PHARMACEUTICAL, INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
cbdMD, Inc. Logo
Produces & distributes lab-tested CBD wellness products for people and pets.
United States of America YCBD
CDT Equity Inc. Logo
Clinical-stage biopharma using AI to enhance and advance therapies for unmet medical needs.
United States of America CDT
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Celcuity Inc. Logo
Developing targeted PI3K/mTOR inhibitor therapies for breast and prostate solid tumors.
United States of America CELC
Celemics, Inc. Logo
Develops custom NGS panels and bioinformatics for research and clinical diagnostics.
South Korea 331920
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
South Korea 308430
CELL BIOTECH CO ., LTD Logo
A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.
South Korea 049960
Celldex Therapeutics, Inc. Logo
Develops antibody-based therapies for severe inflammatory, allergic, and autoimmune diseases.
United States of America CLDX
Cellectar Biosciences, Inc. Logo
Late-stage biopharma developing targeted cancer therapies with a proprietary PDC delivery platform.
United States of America CLRB
Cellectis Logo
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
France ALCLS

Talk to a Data Expert

Have a question? We'll get back to you promptly.